Acupuncture in the Regulation of Dai Meridian for Polycystic Ovarian Syndrome Patients With Abdominal Obesity

Launched by DONGFANG HOSPITAL BEIJING UNIVERSITY OF CHINESE MEDICINE · May 25, 2016

Keywords

ClinConnect Summary

Obesity, especially abdominal obesity, is one of most common clinical features of polycystic ovary syndrome, a widely and seriously influenced complex disorder related to reproduction and metabolism. Excessive accumulation of adipose tissue in the abdominal organs often leads to insulin resistance, which will increase the harm of hyperandrogenism and exacerbate ovulation disorders and metabolic abnormalities.

Weight loss, likely beneficial for both reproductive and metabolic dysfunction in this setting , has been generally recommended as a first-line therapy for obese women with PCOS and c...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of Polycystic Ovarian Syndrome.
• • Clinical diagnosis of abdominal obesity.
• • Agree to participate in clinical trials.
• Exclusion Criteria:
• • Endocrine or neoplastic causes of amenorrhoea, anovulation and hyperandrogenemia, including central nervous system abnormalities, premature ovarian failure, thyroid disease, Cushing's syndrome,androgen secreting tumors, congenital adrenal hyperplasia, and hyperprolactinaemia.
• • Patients suffering from other serious diseases(cardiocerebrovascular diseases, damage to the function of liver and kidney, and mental illness).
• • Patients taking hormonal and metabolic drugs within 12 weeks of study entry affecting the judgment of results.
• • Pregnant or breast feeding.